We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Magenta Therapeutics

News List

Avrobio and Magenta Therapeutics Collaborate contractpharma
May 07, 2020
Evaluate targeted antibody-drug conjugate as a potential conditioning regimen for lentiviral gene therapies.
Magenta stem cell transplant drug seems to work, but is it safe? fiercebiotech
November 02, 2018
Magenta’s stem cell therapy MGTA-456 met efficacy targets in the first few patients enrolled in a phase 2 trial to be presented at ASH next month, but with a question about safety.
Magenta Therapeutics Snags $52 Million to Advance Bone Marrow Transplant Medications biospace
April 10, 2018
Fresh off of striking a research deal with Ladenburg, Germany-based Heidelberg Pharma GmbH, Magenta Therapeutics secured $52 million in Series C financing.
Magenta Therapeutics collaborates with Heidelberg Pharma for Bone Marrow Transplants biospace
March 07, 2018
Cambridge, Massachusetts-based Magenta Therapeutics is teaming up with Ladenburg, Germany-based Heidelberg Pharma GmbH to improve curative bone marrow transplantation.